Development
Tharimmune, Inc.
THAR
$1.51
-$0.0001-0.01%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 42.02% | 4.73% | 12.88% | 59.75% | 659.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.30% | -13.27% | 44.46% | 100.89% | 1,638.58% |
| Operating Income | -43.30% | 13.27% | -44.46% | -100.89% | -1,638.58% |
| Income Before Tax | -40.05% | 14.45% | -42.76% | 8.64% | -172.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.05% | 14.45% | -42.76% | 8.64% | -172.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.05% | 14.45% | -42.76% | 8.64% | -172.01% |
| EBIT | -43.30% | 13.27% | -44.46% | -100.89% | -1,638.58% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 81.39% | 42.95% | -10.51% | 16.10% | -139.72% |
| Normalized Basic EPS | 81.39% | 42.95% | -10.52% | 16.10% | -170.71% |
| EPS Diluted | 81.39% | 42.95% | -10.51% | 16.10% | -139.72% |
| Normalized Diluted EPS | 81.39% | 42.95% | -10.52% | 16.10% | -170.71% |
| Average Basic Shares Outstanding | 652.47% | 49.97% | 29.19% | 8.89% | 81.28% |
| Average Diluted Shares Outstanding | 652.47% | 49.97% | 29.19% | 8.89% | 81.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |